Healthtech unicorn Innovaccer has more than doubled its valuation in its latest Series E funding round of $150 million, and is now valued at $3.2 billion.
Innovaccer was the second Indian startup to cross the billion-dollar valuation mark in February this year with a valuation of $1.3 billion.
The latest Series E round of funding was led by Mubadala Capital, with participation from existing investors B Capital Group, Microsoft’s M12 fund, OMERS Growth Equity, Dragoneer, Steadview Capital, Tiger Global Management, and new investors Whale Rock Capital Management, Avidity Partners, and Schonfeld Strategic Advisors.
Innovaccer plans to use the fresh funds to invest in R&D and recruit new hires as it rapidly scales its customer experience, product, and engineering talent.
